Moxonidine
目录号: A11317
ACE 抑制剂/Beta blocker
Moxonidine 是一种新一代的中枢作用型降压药。当噻嗪类利尿剂、β-阻滞剂、ACE抑制剂和钙通道阻滞剂不适用或未能控制血压时,它可能有其作用。此外,它在胰岛素抵抗综合征的参数上显示出有利的效果,这似乎与降低血压无关。
全国免运费, 顺丰次日达
重要通知:仅供研究使用。我们不向患者销售。
ACE 抑制剂/Beta blocker
重要通知:仅供研究使用。我们不向患者销售。
Discription | Moxonidine is a new-generation centrally-acting antihypertensive drug. It may have a role when thiazides, beta-blockers, ACE inhibitors and calcium channel blockers are not appropriate or have failed to control blood pressure. In addition, it demonstrates favourable effects on parameters of the insulin resistance syndrome, apparently independent of blood pressure reduction. |
---|
目录号 | A11317 |
---|---|
分子式 | C9H12ClN5O |
分子量 | 241.68 |
CAS号 | 75438-57-2 |
SMILES | CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 23 mg/mL (95.16 mM) | |
Water | Insoluble | ||
Ethanol | 2 mg/mL (8.27 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 41.38 mL | 206.89 mL | 413.77 mL |
0.5 mM | 8.28 mL | 41.38 mL | 82.75 mL |
1 mM | 4.14 mL | 20.69 mL | 41.38 mL |
5 mM | 0.83 mL | 4.14 mL | 8.28 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2